MX2011005899A - Pharmaceutical composition with non-sedative antihistamine and combinations thereof. - Google Patents

Pharmaceutical composition with non-sedative antihistamine and combinations thereof.

Info

Publication number
MX2011005899A
MX2011005899A MX2011005899A MX2011005899A MX2011005899A MX 2011005899 A MX2011005899 A MX 2011005899A MX 2011005899 A MX2011005899 A MX 2011005899A MX 2011005899 A MX2011005899 A MX 2011005899A MX 2011005899 A MX2011005899 A MX 2011005899A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
combinations
antihistamine
sedative antihistamine
sedative
Prior art date
Application number
MX2011005899A
Other languages
Spanish (es)
Inventor
Hector Senosiain Arroyo
Luisa Hernandez Ramirez
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Priority to MX2011005899A priority Critical patent/MX2011005899A/en
Publication of MX2011005899A publication Critical patent/MX2011005899A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention refers to a pharmaceutical composition in capsules with microspheres, which comprises an antihistamine, a decongestant and pharmaceutically acceptable vehicles or excipients; the invention also refers to a process for the manufacture of the composition and the use thereof as an antihistamine and nasal decongestant.
MX2011005899A 2011-06-03 2011-06-03 Pharmaceutical composition with non-sedative antihistamine and combinations thereof. MX2011005899A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2011005899A MX2011005899A (en) 2011-06-03 2011-06-03 Pharmaceutical composition with non-sedative antihistamine and combinations thereof.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011005899A MX2011005899A (en) 2011-06-03 2011-06-03 Pharmaceutical composition with non-sedative antihistamine and combinations thereof.

Publications (1)

Publication Number Publication Date
MX2011005899A true MX2011005899A (en) 2013-01-10

Family

ID=48144401

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011005899A MX2011005899A (en) 2011-06-03 2011-06-03 Pharmaceutical composition with non-sedative antihistamine and combinations thereof.

Country Status (1)

Country Link
MX (1) MX2011005899A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022023463A1 (en) 2020-07-30 2022-02-03 Faes Farma, S.A. Decongestant drug delivery system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022023463A1 (en) 2020-07-30 2022-02-03 Faes Farma, S.A. Decongestant drug delivery system

Similar Documents

Publication Publication Date Title
PH12015501595A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
PH12015501598A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
MX2013008850A (en) Compositions and methods for treating cardiovascular diseases.
WO2014064410A3 (en) Pharmaceutical composition comprising tiotropium and a hydrofluoroalkane
PH12015501600A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
MY188450A (en) Spiro-lactam nmda receptor modulators and uses thereof
WO2012174158A3 (en) Administration of benzodiazepine
MX359288B (en) Ivabradine hydrochloride form iv.
IN2013MU03583A (en)
IN2014MN02236A (en)
WO2014076712A3 (en) Lurasidone hydrochloride solid dispersion
WO2012162439A3 (en) Compositions comprising fusidic acid and packages therefor
MX2012001691A (en) Orally disintegrating compositions of linaclotide.
CL2015001615A1 (en) A pharmaceutical composition comprising vortioxetine and donepezil together with a pharmaceutically acceptable excipient; and its use for the treatment of cognitive dysfunction, dementia in Alzheimer's disease, cognitive dysfunction associated with depression and schizophrenia, among other diseases.
CL2013003700A1 (en) Topical ophthalmological pharmaceutical composition comprising regorafenib, which is suspended in a pharmaceutically acceptable vehicle; manufacturing procedure and its use to treat or prevent an ophthalmological disorder.
MX363699B (en) Co-micronisation product comprising ulipristal acetate.
UA112764C2 (en) OPTIMIZED SYNTHESIS OF PURE, NON-POLYMORPHIC CRYSTALLIC bile acids with a predetermined particle size
TN2015000267A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
WO2010079433A3 (en) Pharmaceutical composition comprising melogliptin
MX2012013178A (en) Broad-spectrum anti-parasitic composition consisting of nitazoxanide, probiotics and prebiotics.
MX2014006201A (en) Imatinib solid dosage forms reconstituted just before use.
MX2011005899A (en) Pharmaceutical composition with non-sedative antihistamine and combinations thereof.
MY197454A (en) Non-enteric pharmaceutical composition comprising crofelemer
WO2014013505A8 (en) Amorphous vildagliptin
WO2014013511A3 (en) Rufinamide solid dispersion

Legal Events

Date Code Title Description
FG Grant or registration